Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Shareholders' Equity

v3.23.2
Consolidated Statements of Shareholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Common Stock
2022 Private Placement.
Common Stock
2021 Underwritten Public Offering
Common Stock
2021 Registered Direct Offering
Common Stock
Equity Distribution Agreement
Common Stock
LPC Purchase Agreement
Common Stock
Registered Direct Offering 2022
Common Stock
Additional Paid-in Capital
2022 Private Placement.
Additional Paid-in Capital
2021 Underwritten Public Offering
2021 Pre-Funded Warrants
Additional Paid-in Capital
2021 Underwritten Public Offering
Additional Paid-in Capital
2021 Registered Direct Offering
Additional Paid-in Capital
Equity Distribution Agreement
Additional Paid-in Capital
LPC Purchase Agreement
Additional Paid-in Capital
Registered Direct Offering 2022
Class A Warrants
Additional Paid-in Capital
Registered Direct Offering 2022
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
2022 Private Placement.
2021 Underwritten Public Offering
2021 Pre-Funded Warrants
2021 Underwritten Public Offering
2021 Registered Direct Offering
Equity Distribution Agreement
LPC Purchase Agreement
Registered Direct Offering 2022
Class A Warrants
Registered Direct Offering 2022
Total
Balance at Jun. 30, 2021             $ 8                 $ 194,229   $ (168,138)                 $ 26,099
Balance (in shares) at Jun. 30, 2021             8,352                                        
Gross proceeds from issuance of common stock for cash   $ 6 $ 1 $ 1   $ 18       $ 39,950 $ 4,999 $ 1,518 $ 1,172   $ 64,372           $ 39,956 $ 5,000 $ 1,519 $ 1,172   $ 64,390  
Gross proceeds from issuance of common stock for cash (in shares)   6,147 769 138 116 18,026                                          
Underwriting commissions, discounts and other equity offering costs                               (4,596)                     (4,596)
Share-based compensation                               3,685                     3,685
Reclassification of derivative liabilities to equity upon cure of authorized share deficiency                               35,025                     35,025
Issuance of commitment shares                         $ 450                     $ 450      
Issuance of commitment shares (in shares)         34                                            
Fair value of warrants issued                 $ 10,783         $ 7,048           $ 10,783         $ 7,048    
Net loss                                   (41,060)                 (41,060)
Balance at Jun. 30, 2022             $ 34                 358,635   (209,198)                 149,471
Balance (in shares) at Jun. 30, 2022             33,582                                        
Gross proceeds from issuance of common stock for cash $ 3             $ 12,327                     $ 12,330                
Gross proceeds from issuance of common stock for cash (in shares) 3,245                                                    
Underwriting commissions, discounts and other equity offering costs                               (759)                     (759)
Share-based compensation                               7,268                     7,268
Net change in accumulated other comprehensive loss                                 $ (351)                   (351)
Net loss                                   (51,787)                 (51,787)
Balance at Jun. 30, 2023             $ 37                 $ 377,471 $ (351) $ (260,985)                 $ 116,172
Balance (in shares) at Jun. 30, 2023             36,827